Figure 1.

Daily changes in plasma glucose and serum C‐peptide levels after initiation of treatment of nivolumab. i.v., intravenous fluid.

Daily changes in plasma glucose and serum C‐peptide levels after initiation of treatment of nivolumab. i.v., intravenous fluid.